SII could seek nod in December for Covishield's limited use

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to apply for an emergency approval from the Indian government next month for using the coronavirus vaccine on corona warriors and the elderly. The vaccine, dubbed "Covishield," has shown splendid results. By April 2021, the general public would get doses, SII CEO Adar Poonawalla said on Thursday.

source https://www.newsbytesapp.com/news/india/serum-wants-emergency-use-authorization-for-covishield/story